68Ga-HA-DOTATATE Imaging of Suspected Somatostatin Receptor Positive Tumors
NCT04888481
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
600
Enrollment
OTHER
Sponsor class
Conditions
Neuroendocrine Tumors
Interventions
DRUG:
68Ga-HA-DOTATATE
Sponsor
University of Alberta